Week of October 25, 2022 | Vol. 11, Issue 42

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners
October 24-26, 2022 - Leipzig, Germany
November 1-3, 2022 - Messe Frankfurt, Germany

JP Morgan Healthcare Conference

January 9-12, 2023 - San Francisco, CA

INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
M&A TRANSACTIONS

Pharma & Biotech

11 transactions totaling $1,494 million


Supplies, Equipment & Services

20 transactions totaling $1,441 million


Healthcare Facilities & Distributors

12 transactions totaling $129 million



Healthcare IT & Managed Care

2 transactions

PRIVATE PLACEMENTS

Pharma & Biotech

30 transactions totaling $1,758 million


Supplies, Equipment & Services

25 transactions totaling $230 million


Healthcare Facilities & Distributors

2 transactions


Healthcare IT & Managed Care

17 transactions totaling $460 million

PUBLIC OFFERINGS

Pharma & Biotech

21 transactions totaling $1,167 million


Supplies, Equipment & Services

6 transactions totaling $145 million


Healthcare Facilities & Distributors

1 transaction


Healthcare IT & Managed Care

0 transactions

TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.






MARKET REPORTS
Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Consumer Health Sector Snapshot Q2 2022

June 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Ester

Sell-side |Pharma| OTC Technology and Products Developer


Project Gateway

Sell-Side |Pharma| Generic Pharmaceuticals


Project Jazz

Sell-Side |Pharma Services| Compounding Pharmacy and Pharmacy Service Provider

Project Panther

Sell-Side| CDMO | Consumer Health and Medical Device


Project Power Play

Buy-Side | Specialty Pharma |Branded & Generic Pharmaceuticals


Project Trident

Buy-Side | Generic Pharma | Manufacturing liquid generics

FEATURED HEADLINES

A Sampling of Industry Headlines

ImaginAb and Cyclotek Enter into Manufacturing and Distribution Agreement for CD8 ImmunoPET Agent in Australia

PR Newswire- October 17, 2022

Yapan Bio Adds New Process Development Facility; Expands Capacity and Capabilities in Large Molecule Therapeutics

PR Newswire - October 18, 2022

BD, Biocorp Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs

B3C Newswire - October 18, 2022

Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership

Business Wire - October 18, 2022

Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility

Quotient Sciences - October 18, 2022

Lysando AG and Amicogen Inc. Sign General Development Agreement

Business Wire - October 18, 2022

Mikart and Fluid Pharma Ltd have entered into a collaboration agreement to manufacture clinical trial materials using proprietary MicroCoat™ technology to advance new therapies

PR Newswire - October 19, 2022

Agreements Showcase Company's Ability to Support Novel Theraputic Programs Regardless of Development Stage

Societal CDMO - October 20, 2022

Veeva inks deals with 40 CROs, expanding digital clinical trial reach

Fierce Biotech - October 20, 2022

Corium and Gurnet Point Capital Announce Manufacturing Business Acquisition and a $100 Million Neuroscience Therapeutics Investment by Webster Equity Partners, Establishing Two Independent Growth Companies

Business Wire - October 20, 2022

TANNER NEWS

Linkedin  

How Technology is Transforming Clinical Trials

The pandemic opened the door for new ideas and technologies that can streamline clinical trial processes for both sponsors and patients. This whitepaper details the affects of COVID-19 on clinical trials and highlights the technologies that are enhancing clinical trial processes and the pharmaceutical supply chain. Access the full resource here.

A Guide to the Key Pharma Markets in Latin America

Bringing new or mature pharmaceuticals, supplements and devices to emerging markets can be complex, but these regions offer great opportunity for pharmaceutical, biotech and healthcare companies. We explore some of the challenges and advantages in bringing products to five of the largest pharma markets in Latin America: Argentina, Brazil, Chile, Columbia, and Mexico. Read more.

Let's Connect!
The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.